Eam Investors, LLC Aerie Pharmaceuticals Inc Transaction History

Eam Investors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 14, 2018	SELL	$51.15 - $61.0 $2.09 Million - $2.49 Million	-40,782 Closed	0 $0
Q4 2017 May 21, 2018	SELL	$50.85 - $65.1 $601,097 - $769,547	-11,821 Reduced 22.47%	40,782 $2.44 Million
Q4 2017 Feb 12, 2018	SELL	$50.85 - $65.1 $766,055 - $980,731	-15,065 Reduced 22.26%	52,603 $3.14 Million
Q3 2017 Nov 08, 2017	BUY	$48.6 - $60.1 $3.29 Million - $4.07 Million	67,668	67,668 $3.29 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.